BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

253 related articles for article (PubMed ID: 24288222)

  • 1. Clinical outcomes of rectal neuroendocrine tumors ≤ 10 mm following endoscopic resection.
    Kim GU; Kim KJ; Hong SM; Yu ES; Yang DH; Jung KW; Ye BD; Byeon JS; Myung SJ; Yang SK; Kim JH
    Endoscopy; 2013 Dec; 45(12):1018-23. PubMed ID: 24288222
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Long-Term Clinical Outcomes of Rectal Neuroendocrine Tumors According to the Pathologic Status After Initial Endoscopic Resection: A KASID Multicenter Study.
    Moon CM; Huh KC; Jung SA; Park DI; Kim WH; Jung HM; Koh SJ; Kim JO; Jung Y; Kim KO; Kim JW; Yang DH; Shin JE; Shin SJ; Kim ES; Joo YE
    Am J Gastroenterol; 2016 Sep; 111(9):1276-85. PubMed ID: 27377520
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Clinical outcomes of endoscopic mucosal resection for rectal neuroendocrine tumor.
    Kim J; Kim JH; Lee JY; Chun J; Im JP; Kim JS
    BMC Gastroenterol; 2018 Jun; 18(1):77. PubMed ID: 29866049
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Long-term prognosis of an endoscopically treated rectal neuroendocrine tumor: 10-year experience in a single institution.
    Sung HY; Kim SW; Kang WK; Kim SY; Jung CK; Cho YK; Park JM; Lee IS; Choi MG; Chung IS
    Eur J Gastroenterol Hepatol; 2012 Aug; 24(8):978-83. PubMed ID: 22647741
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Excellent prognosis following endoscopic resection of patients with rectal neuroendocrine tumors despite the frequent presence of lymphovascular invasion.
    Sekiguchi M; Sekine S; Sakamoto T; Otake Y; Nakajima T; Matsuda T; Taniguchi H; Kushima R; Ohe Y; Saito Y
    J Gastroenterol; 2015 Dec; 50(12):1184-9. PubMed ID: 25936647
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The Ki-67 labeling index and lymphatic/venous permeation predict the metastatic potential of rectal neuroendocrine tumors.
    Sugimoto S; Hotta K; Shimoda T; Imai K; Yamaguchi Y; Nakajima T; Oishi T; Mori K; Takizawa K; Kakushima N; Tanaka M; Kawata N; Matsubayashi H; Ono H
    Surg Endosc; 2016 Oct; 30(10):4239-48. PubMed ID: 26718357
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Prognostic Factors for Locoregional Recurrence in Neuroendocrine Tumors of the Rectum.
    Tsang ES; McConnell YJ; Schaeffer DF; Yin Y; Speers CH; Kennecke HF
    Dis Colon Rectum; 2018 Feb; 61(2):187-192. PubMed ID: 29337773
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Lymphovascular invasion in more than one-quarter of small rectal neuroendocrine tumors.
    Kwon MJ; Kang HS; Soh JS; Lim H; Kim JH; Park CK; Park HR; Nam ES
    World J Gastroenterol; 2016 Nov; 22(42):9400-9410. PubMed ID: 27895428
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Endoscopic resection yields reliable outcomes for small rectal neuroendocrine tumors.
    Jeon JH; Cheung DY; Lee SJ; Kim HJ; Kim HK; Cho HJ; Lee IK; Kim JI; Park SH; Kim JK
    Dig Endosc; 2014 Jul; 26(4):556-63. PubMed ID: 24447261
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Recurrence pattern and surveillance strategy for rectal neuroendocrine tumors after endoscopic resection.
    Chung HG; Goh MJ; Kim ER; Hong SN; Kim TJ; Chang DK; Kim YH
    J Gastroenterol Hepatol; 2021 Apr; 36(4):968-973. PubMed ID: 32864790
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Short- and long-term outcomes of endoscopic resection of rectal neuroendocrine tumours: analyses according to the WHO 2010 classification.
    Nakamura K; Osada M; Goto A; Iwasa T; Takahashi S; Takizawa N; Akahoshi K; Ochiai T; Nakamura N; Akiho H; Itaba S; Harada N; Iju M; Tanaka M; Kubo H; Somada S; Ihara E; Oda Y; Ito T; Takayanagi R
    Scand J Gastroenterol; 2016; 51(4):448-55. PubMed ID: 26540372
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Criteria for decision making after endoscopic resection of well-differentiated rectal carcinoids with regard to potential lymphatic spread.
    Park CH; Cheon JH; Kim JO; Shin JE; Jang BI; Shin SJ; Jeen YT; Lee SH; Ji JS; Han DS; Jung SA; Park DI; Baek IH; Kim SH; Chang DK
    Endoscopy; 2011 Sep; 43(9):790-5. PubMed ID: 21735371
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Transanal endoscopic microsurgery for residual rectal cancer (ypT0-2) following neoadjuvant chemoradiation therapy: another word of caution.
    Perez RO; Habr-Gama A; Lynn PB; São Julião GP; Bianchi R; Proscurshim I; Gama-Rodrigues J
    Dis Colon Rectum; 2013 Jan; 56(1):6-13. PubMed ID: 23222274
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Full-thickness excision using transanal endoscopic microsurgery for treatment of rectal neuroendocrine tumors.
    Chen WJ; Wu N; Zhou JL; Lin GL; Qiu HZ
    World J Gastroenterol; 2015 Aug; 21(30):9142-9. PubMed ID: 26290641
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Short- and Long-term Outcomes of Laparoscopic Total Mesenteric Excision for Neuroendocrine Tumors of the Rectum.
    Takatsu Y; Fukunaga Y; Nagasaki T; Akiyoshi T; Konishi T; Fujimoto Y; Nagayama S; Ueno M
    Dis Colon Rectum; 2017 Mar; 60(3):284-289. PubMed ID: 28177990
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Is endoscopic ultrasonography essential for endoscopic resection of small rectal neuroendocrine tumors?
    Park SB; Kim DJ; Kim HW; Choi CW; Kang DH; Kim SJ; Nam HS
    World J Gastroenterol; 2017 Mar; 23(11):2037-2043. PubMed ID: 28373770
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Cap-assisted EMR for rectal neuroendocrine tumors: comparisons with conventional EMR and endoscopic submucosal dissection (with videos).
    Yang DH; Park Y; Park SH; Kim KJ; Ye BD; Byeon JS; Myung SJ; Yang SK
    Gastrointest Endosc; 2016 May; 83(5):1015-22; quiz 1023-.e6. PubMed ID: 26460225
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Surgical salvage of recurrent rectal cancer after transanal excision.
    Weiser MR; Landmann RG; Wong WD; Shia J; Guillem JG; Temple LK; Minsky BD; Cohen AM; Paty PB
    Dis Colon Rectum; 2005 Jun; 48(6):1169-75. PubMed ID: 15793645
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Long-term outcomes according to additional treatments after endoscopic resection for rectal small neuroendocrine tumors.
    Cha JH; Jung DH; Kim JH; Youn YH; Park H; Park JJ; Um YJ; Park SJ; Cheon JH; Kim TI; Kim WH; Lee HJ
    Sci Rep; 2019 Mar; 9(1):4911. PubMed ID: 30894571
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Clinical Outcomes of Patients with Small Rectal Neuroendocrine Tumors Treated Using Endoscopic Submucosal Resection with a Ligation Device.
    Takita M; Sakai E; Nakao T; Kimoto Y; Ishii R; Konishi T; Ueno S; Kanda K; Negishi R; Muramoto T; Hashimoto H; Morikawa T; Matsuhashi N; Ohata K
    Digestion; 2019; 99(1):72-78. PubMed ID: 30554202
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.